Surrogate markers, atherosclerosis and cardiovascular disease prevention.
Wierzbicki
A S
AS
Department of Chemical Pathology, St. Thomas' Hospital, London, UK. anthony.wierzbicki@kcl.ac.uk
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000175:diagnosis*; D015415:Biomarkers / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D012307:Risk Factors; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D015415:Biomarkers